0001235802-19-000139.txt : 20191206 0001235802-19-000139.hdr.sgml : 20191206 20191206165151 ACCESSION NUMBER: 0001235802-19-000139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191205 FILED AS OF DATE: 20191206 DATE AS OF CHANGE: 20191206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wallace Steven P. CENTRAL INDEX KEY: 0001763512 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35065 FILM NUMBER: 191273626 MAIL ADDRESS: STREET 1: 1023 CHERRY ROAD CITY: MEMPHIS STATE: TN ZIP: 38117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wright Medical Group N.V. CENTRAL INDEX KEY: 0001492658 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 980509600 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1229 BUSINESS ADDRESS: STREET 1: PRINS BERNHARDPLEIN 200 CITY: AMSTERDAM STATE: P7 ZIP: 1097JB BUSINESS PHONE: 901-867-4317 MAIL ADDRESS: STREET 1: 1023 CHERRY ROAD CITY: MEMPHIS STATE: TN ZIP: 38117 FORMER COMPANY: FORMER CONFORMED NAME: Tornier N.V. DATE OF NAME CHANGE: 20110201 FORMER COMPANY: FORMER CONFORMED NAME: Tornier B.V. DATE OF NAME CHANGE: 20100524 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-12-05 0 0001492658 Wright Medical Group N.V. WMGI 0001763512 Wallace Steven P. 1023 CHERRY ROAD MEMPHIS TN 38117 0 1 0 0 President, International Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 M 0 7634 26.81 A 21649 D Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 M 0 5412 27.86 A 27061 D Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 M 0 4176 24.49 A 31237 D Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 S 0 17222 29.6001 D 14015 D Stock Option (right to buy) 26.81 2019-12-05 4 M 0 7634 0 D 2027-02-16 Ordinary Shares 7634 3482 D Stock Option (right to buy) 27.86 2019-12-05 4 M 0 5412 0 D 2027-07-25 Ordinary Shares 5412 3875 D Stock Option (right to buy) 24.49 2019-12-05 4 M 0 4176 0 D 2028-07-24 Ordinary Shares 4176 8360 D Exercise and sale of vested stock options in connection with 280G tax planning Includes 1,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 5,232 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,939 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.605, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. This option vested with respect to 25% of the shares on February 16, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. /s/Marija Nelson, attorney-in-fact 2019-12-06